Results 221 to 230 of about 53,202 (260)
Some of the next articles are maybe not open access.
Can GLP-1RAs redefine transplantation standard of care?
Trends in Pharmacological SciencesMetabolic derangements, particularly obesity and post-transplant diabetes mellitus, remain major challenges in solid organ transplantation, contributing to graft dysfunction and increased morbidity. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as promising agents due to their glucose-lowering, weight-reducing, and cardiorenal ...
openaire +2 more sources
Kniearthrose: Lange GLP-1RA-Therapie ist krankheitsmodifizierend
Aktuelle RheumatologieEine Gewichtsreduktion gilt als eine der ersten Maßnahmen bei Kniearthrose (KOA). Jüngste Erkenntnisse deuten darauf hin, dass bei Diabetes mellitus Typ 2 empfohlene Glucagonlike-Peptid-1-Rezeptor-Agonisten (GLP-1RAs), die eine Gewichtsreduktion bewirken, eine geringe Verbesserung ...
openaire +1 more source
IP06-36 CHARACTERIZING KIDNEY STONE EPISODES BY GLP-1RA MEDICATION IN GLP-1RA USERS
Journal of UrologyShreya Thiagarajan +3 more
openaire +1 more source
The benefit of GLP-1RA in different age groups in the cardiovascular outcome trials
Diabetes Research and Clinical Practice, 2021Basem Mishriky +2 more
exaly
SGLT2i and GLP-1RA Use in the USA
Journal of General Internal MedicineKyle Steiger, Rozalina G. McCoy
openaire +1 more source

